Abstract
AbstractThe coronavirus disease 2019 (COVID-19) pandemic has continued for more than 3 years, placing a huge burden on society worldwide. Although the World Health Organization (WHO) has declared an end to COVID-19 as a Public Health Emergency of International Concern (PHEIC), it is still considered a global threat. Previously, there has been a long debate as to whether the COVID-19 emergency will eventually end or transform into a more common infectious disease from a PHEIC, and how should countries respond to similar pandemics in the future more time-efficiently and cost-effectively. We reviewed the past, middle and current situation of COVID-19 based on bibliometric analysis and epidemiological data. Thereby, the necessity is indicated to change the paradigm from reactive healthcare services to predictive, preventive and personalised medicine (PPPM) approach, in order to effectively protect populations against COVID-19 and any future pandemics. Corresponding measures are detailed in the article including the involvement of multi-professional expertise, application of artificial intelligence, rapid diagnostics and patient stratification, and effective protection, amongst other to be considered by advanced health policy.
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Health Policy,Drug Discovery
Reference47 articles.
1. WHO. WHO Coronavirus (COVID-19) Dashboard - Global Situation. 2023. https://covid19.who.int/. Accessed 29 May 2023.
2. Statista Research Department. Share of gross domestic product (GDP) lost as a result of the coronavirus pandemic (COVID-19) in 2020, by economy. 2023. https://www.statista.com/statistics/1240594/gdp-loss-covid-19-economy/. Accessed 29 May 2023.
3. Ghebreyesus TA. WHO chief declares end to COVID-19 as a global health emergency. 2023. https://news.un.org/en/story/2023/05/1136367. Accessed 29 May 2023.
4. Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V. Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J. 2013;4:12. https://doi.org/10.1186/1878-5085-4-12.
5. Meng X, Wang F, Gao X, Wang B, Xu X, Wang Y, et al. Association of IgG N-glycomics with prevalent and incident type 2 diabetes mellitus from the paradigm of predictive, preventive, and personalized medicine standpoint. EPMA J. 2023;14:1–20. https://doi.org/10.1007/s13167-022-00311-3.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献